Cellectar Biosciences, Inc. (CLRB) vs IRIDEX Corporation (IRIX)
A side-by-side comparison of Cellectar Biosciences, Inc. and IRIDEX Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
IRIX
IRIDEX Corporation
$0.70HealthcareDelayed quote: Oct 6, 2026, 12:16 PM EDT
Total return — CLRB vs IRIX
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-54.9%/yr)IRIX -95.2% (-26.2%/yr)IRIX compounded faster over this window
Log scale — wide-divergence pair
CLRB IRIX
CLRB vs IRIX: by the numbers
- •CLRB is the larger company ($13M vs $12M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -6.88% net margin).
Metrics side by side
Valuation
| Metric | CLRB | IRIX |
|---|---|---|
| P/S ratio | N/A | 0.24 |
| P/B ratio | 0.43 | N/A |
Profitability
| Metric | CLRB | IRIX |
|---|---|---|
| Gross margin | 0.00% | 36.23% |
| Operating margin | 0.00% | -5.39% |
| Net margin | 0.00% | -6.88% |
| ROE | -74.73% | -97.47% |
| ROIC | -74.94% | -19.53% |
Growth (annualized)
| Metric | CLRB | IRIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.57% |
| Total return CAGR (5Y) | -60.51% | -38.13% |
Frequently asked
- How have CLRB and IRIX total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and IRIX delivered -26.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.